Brandon Mahal, MD, discusses the emerging role of epigenomics in prostate cancer.
Brandon Mahal, MD
Advertisement
Articles by Brandon Mahal, MD
Brandon Mahal, MD, assistant professor of radiation oncology, assistant director of community outreach and engagement, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses the prevalence of prostate cancer among African American men.
Brandon Mahal, MD, discusses the potential role of race with regard to molecular disparities among men with prostate cancer.
Advertisement
Latest Updated Articles
Dr. Mahal on the Emerging Role of Epigenomics in Prostate CancerPublished: November 5th 2020 | Updated:
Dr. Mahal on the Prevalence of Prostate Cancer in African American MenPublished: November 2nd 2020 | Updated:
Dr. Mahal on the Potential Role of Race in Prostate Cancer DisparitiesPublished: October 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
5